BHVN News and Press, Biohaven Pharmaceutical Holding Company Ltd.

2024-06-28 10:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Healthcare stocks to buy have been off to the races recently — especially the ones in the weight-loss drug market. Indeed, the market is huge and could entail considerable growth for...

2024-06-05 20:20:00 ET Summary In May, the S&P Total Return index was up almost +5%, a bounce back and some, but we question the foundation for which this move up is built. According to the folks at S&P Down Jones Indices (link), Q1 earnings per share for the S&P 500 i...

2024-05-30 11:22:06 ET More on Eli Lilly, Novo, etc. Novo Nordisk: The Market Is Right, Don't Fight Against It Novo Nordisk: Not The Best Investment Right Now, But A Great Case Study Novo Nordisk: Considerable Growth Beyond Ozempic Lilly's Retevmo gains appro...

2024-05-29 12:00:07 ET Brian Skorney from Robert W. Baird issued a price target of $58.00 for BHVN on 2024-05-29 09:57:00. The adjusted price target was set to $58.00. At the time of the announcement, BHVN was trading at $30.31. The overall price target consensus is at $...

2024-05-29 11:00:21 ET Leonid Timashev from RBC Capital issued a price target of $59.00 for BHVN on 2024-05-29 09:14:00. The adjusted price target was set to $59.00. At the time of the announcement, BHVN was trading at $28.69. The overall price target consensus is at $23...

A look at the top 10 most actives in the United States ReShape Lifesciences Inc. (RSLS) rose 89.7% to $0.3942 on volume of 109,324,190 shares Faraday Future Intelligent Electric Inc. (FFIE) fell 30.3% to $0.8151 on volume of 100,649,842 shares Innovative Eyewear Inc. (LUCY) rose 61.0% to ...

2024-05-29 10:00:15 ET More on Health Care Select Sector SPDR XLV: Healthcare Is Ripe For Buying, Despite Patent Cliff XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care Short interest in S&P 500 ...

2024-05-29 09:27:44 ET More on Biohaven Biohaven: Promising Pipeline With Troriluzole, Taldefgrobep Alfa, And BHV-7000 Leading The Charge Biohaven drops 4%, prices $230M share offering Biohaven stock slides 15% amid data presentations Seeking Alpha’s Q...

2024-05-29 08:42:13 ET AERWINS Technologies AWIN -35% on Q1 earnings release . Biohaven ( BHVN ) -30% after BHV-1510, a novel Trop-2 directed antibody drug conjugate, has shown promising preclinical efficacy and potential for wider therapeutic margin . The company ...

Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D Day Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple The...